Answer
Trisenox (arsenic trioxide) is administered intravenously over 1–2 hours under a physician experienced in acute leukaemias, with required monitoring; infusion may extend to four hours if vasomotor reactions occur, a central venous catheter is unnecessary, and hospitalisation is required at treatment initiation.
Sources for this answer
- Trisenox (arsenic trioxide) 2mg/ml Concentrate for Solution for InfusionTeva Pharma B.V. · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked